NCT02340728View on ClinicalTrials.gov

Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions

Pancreatic CancerUnresectable Biliary-pancreatic Malignancies

Interventions

DEVICE

ERCP with SEMS plus radiofrequency ablation

DEVICE

ERCP with SEMS alone (standard of care)

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02340728 - Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies | Biotech Hunter | Biotech Hunter